Literature DB >> 21907012

ST3GAL3 mutations impair the development of higher cognitive functions.

Hao Hu1, Katinka Eggers, Wei Chen, Masoud Garshasbi, M Mahdi Motazacker, Klaus Wrogemann, Kimia Kahrizi, Andreas Tzschach, Masoumeh Hosseini, Ideh Bahman, Tim Hucho, Martina Mühlenhoff, Rita Gerardy-Schahn, Hossein Najmabadi, H Hilger Ropers, Andreas W Kuss.   

Abstract

The genetic variants leading to impairment of intellectual performance are highly diverse and are still poorly understood. ST3GAL3 encodes the Golgi enzyme β-galactoside-α2,3-sialyltransferase-III that in humans predominantly forms the sialyl Lewis a epitope on proteins. ST3GAL3 resides on chromosome 1 within the MRT4 locus previously identified to associate with nonsyndromic autosomal recessive intellectual disability. We searched for the disease-causing mutations in the MRT4 family and a second independent consanguineous Iranian family by using a combination of chromosome sorting and next-generation sequencing. Two different missense changes in ST3GAL3 cosegregate with the disease but were absent in more than 1000 control chromosomes. In cellular and biochemical test systems, these mutations were shown to cause ER retention of the Golgi enzyme and drastically impair ST3Gal-III functionality. Our data provide conclusive evidence that glycotopes formed by ST3Gal-III are prerequisite for attaining and/or maintaining higher cognitive functions.
Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907012      PMCID: PMC3169827          DOI: 10.1016/j.ajhg.2011.08.008

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  48 in total

1.  Sialylation is essential for early development in mice.

Authors:  Martina Schwarzkopf; Klaus-Peter Knobeloch; Elvira Rohde; Stephan Hinderlich; Nicola Wiechens; Lothar Lucka; Ivan Horak; Werner Reutter; Rüdiger Horstkorte
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

Review 2.  Endoplasmic reticulum-associated protein degradation.

Authors:  Ernst Jarosch; Uwe Lenk; Thomas Sommer
Journal:  Int Rev Cytol       Date:  2003

3.  Voltage-gated potassium channel antibody associated mood disorder without paraneoplastic disease.

Authors:  Suzanna Kitten; Nitika Gupta; Richard M Bloch; Charles K Dunham
Journal:  Biol Psychiatry       Date:  2011-04-30       Impact factor: 13.382

Review 4.  Congenital disorders of glycosylation: a review.

Authors:  Stephanie Grunewald; Gert Matthijs; Jaak Jaeken
Journal:  Pediatr Res       Date:  2002-11       Impact factor: 3.756

5.  Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase.

Authors:  H Kitagawa; J C Paulson
Journal:  Biochem Biophys Res Commun       Date:  1993-07-15       Impact factor: 3.575

Review 6.  Glycans and neural cell interactions.

Authors:  Ralf Kleene; Melitta Schachner
Journal:  Nat Rev Neurosci       Date:  2004-03       Impact factor: 34.870

Review 7.  Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies.

Authors:  T Marquardt; J Denecke
Journal:  Eur J Pediatr       Date:  2003-03-15       Impact factor: 3.183

Review 8.  Role of glycosylation in development.

Authors:  Robert S Haltiwanger; John B Lowe
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

9.  Cloning and sequencing of nineteen transcript isoforms of the human alpha2,3-sialyltransferase gene, ST3Gal III; its genomic organisation and expression in human tissues.

Authors:  Ammi Grahn; Giti Shah Barkhordar; Göran Larson
Journal:  Glycoconj J       Date:  2002-03       Impact factor: 2.916

10.  Sialyltransferase specificity in selectin ligand formation.

Authors:  Lesley G Ellies; Markus Sperandio; Gregory H Underhill; James Yousif; Michael Smith; John J Priatel; Geoffrey S Kansas; Klaus Ley; Jamey D Marth
Journal:  Blood       Date:  2002-07-25       Impact factor: 22.113

View more
  28 in total

1.  A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.

Authors:  Luigi Boccuto; Kazuhiro Aoki; Heather Flanagan-Steet; Chin-Fu Chen; Xiang Fan; Frank Bartel; Marharyta Petukh; Ayla Pittman; Robert Saul; Alka Chaubey; Emil Alexov; Michael Tiemeyer; Richard Steet; Charles E Schwartz
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

Review 2.  Neurological aspects of human glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Annu Rev Neurosci       Date:  2015-04-02       Impact factor: 12.449

3.  Sialylation regulates brain structure and function.

Authors:  Seung-Wan Yoo; Mary G Motari; Keiichiro Susuki; Jillian Prendergast; Andrea Mountney; Andres Hurtado; Ronald L Schnaar
Journal:  FASEB J       Date:  2015-04-06       Impact factor: 5.191

4.  Glycosyltransferase genes that cause monogenic congenital disorders of glycosylation are distinct from glycosyltransferase genes associated with complex diseases.

Authors:  Hiren J Joshi; Lars Hansen; Yoshiki Narimatsu; Hudson H Freeze; Bernard Henrissat; Eric Bennett; Hans H Wandall; Henrik Clausen; Katrine T Schjoldager
Journal:  Glycobiology       Date:  2018-05-01       Impact factor: 4.313

5.  TRAPPC9-related autosomal recessive intellectual disability: report of a new mutation and clinical phenotype.

Authors:  Giuseppe Marangi; Vincenzo Leuzzi; Filippo Manti; Serena Lattante; Daniela Orteschi; Vanna Pecile; Giovanni Neri; Marcella Zollino
Journal:  Eur J Hum Genet       Date:  2012-05-02       Impact factor: 4.246

6.  Mutations in NSUN2 cause autosomal-recessive intellectual disability.

Authors:  Lia Abbasi-Moheb; Sara Mertel; Melanie Gonsior; Leyla Nouri-Vahid; Kimia Kahrizi; Sebahattin Cirak; Dagmar Wieczorek; M Mahdi Motazacker; Sahar Esmaeeli-Nieh; Kirsten Cremer; Robert Weißmann; Andreas Tzschach; Masoud Garshasbi; Seyedeh S Abedini; Hossein Najmabadi; H Hilger Ropers; Stephan J Sigrist; Andreas W Kuss
Journal:  Am J Hum Genet       Date:  2012-04-26       Impact factor: 11.025

Review 7.  Understanding human glycosylation disorders: biochemistry leads the charge.

Authors:  Hudson H Freeze
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

Review 8.  Human genetic disorders involving glycosylphosphatidylinositol (GPI) anchors and glycosphingolipids (GSL).

Authors:  Bobby G Ng; Hudson H Freeze
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

9.  A patient-specific induced pluripotent stem cell model for West syndrome caused by ST3GAL3 deficiency.

Authors:  Laura van Diepen; Falk F R Buettner; Dirk Hoffmann; Christina T Thiesler; Oliver von Bohlen Und Halbach; Viola von Bohlen Und Halbach; Lars R Jensen; Doris Steinemann; Simon Edvardson; Orly Elpeleg; Axel Schambach; Rita Gerardy-Schahn; Andreas W Kuss
Journal:  Eur J Hum Genet       Date:  2018-08-08       Impact factor: 4.246

10.  Novel Loci Associated With Attention-Deficit/Hyperactivity Disorder Are Revealed by Leveraging Polygenic Overlap With Educational Attainment.

Authors:  Alexey A Shadrin; Olav B Smeland; Tetyana Zayats; Andrew J Schork; Oleksandr Frei; Francesco Bettella; Aree Witoelar; Wen Li; Jon A Eriksen; Florian Krull; Srdjan Djurovic; Stephen V Faraone; Ted Reichborn-Kjennerud; Wesley K Thompson; Stefan Johansson; Jan Haavik; Anders M Dale; Yunpeng Wang; Ole A Andreassen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2017-11-26       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.